Skip to main content

Could MKK7 be a new treatment target to reduce heart damage after a heart attack?

Dr Xin Wang (lead researcher)

University of Manchester

Start date: 01 January 1900 (Duration 3 years)

Investigating cardioprotective system against myocardial infarction: is mitogen activated protein kinase kinase 7 (MKK7) a new player? (Ms Tayyiba Azam)

Manchester researchers are studying a protein in the heart that they believe could have protective properties for heart cells. During a heart attack, a portion of the heart is starved of its blood supply. This kills or injures a large number of heart muscle cells, which can lead to severe long term health problems such as heart failure. A range of treatments exist to restore the blood supply to the heart, but we don’t have current treatments to prevent heart cell death. This team are investigating a protein in the heart that they believe has this potential Dr Wang and colleagues at the University of Manchester have demonstrated that when a protein known as MKK7 is deleted in heart cells of mice, they are much more vulnerable to cell death. This suggests that it is involved in a protective system that we may be able to harness in humans. In this project they will delve deeper into the role of MKK7; studying if and how it protects against cell death after heart attack. They will do this both in animals with changes in MKK7 and then in specially-modified human heart cells. If successful, the ultimate goal is to design a new medicine that can boost the effects of MKK7. This could prevent or reduce cell death following a heart attack, reducing people’s risk of death or heart failure.

Project details

Grant amount £115,166
Grant type Fellowships
Application type PhD Studentship
Start Date 01 January 1900
Duration 3 years
Reference FS/19/39/34447
Status In Progress
How much would you like to donate?
Donate
Payment methods
How much would you like to donate?
Donate monthly
Direct Debit Logo